By Mark Terry
BioSpace — Laboratory Corporation of America Holdings, or LabCorp, is one of the two largest clinical diagnostic laboratory companies in the U.S. The company announced its Covance drug development business was launching COVID-19 Clinical Trial Connect in the U.S. to help people find information on taking part in clinical trials related to COVID-19.
The site specifically notes five categories of potential participation: if you have been exposed to a confirmed case of COVID-19; if you are experiencing COVID-19 symptoms; if you have been diagnosed with COVID-19; if you have recovered from a confirmed case of COVID-19 infection; and if you are healthy or have interest in vaccine research studies.
“Our goal is to link people interested in these clinical trials with sponsors so that together we may find solutions for this global pandemic,” said Michael Brooks, Covance’s president of Clinical Development and Commercialization Solutions.